Hollie E. Flick, Ph.D. - Publications
Affiliations: | 2013 | Biochemistry | Drexel University College of Medicine, Philadelphia, PA, United States |
Area:
Pharmacology, Oncology, Molecular BiologyYear | Citation | Score | |||
---|---|---|---|---|---|
2014 | Muller AJ, Smith C, Chang MY, DuHadaway J, Mondal A, Flick H, Parker K, Beury D, Ostrand-Rosenberg S, Prendergast GC. Abstract 3665: IDO1 is an integrative determinant of tumor-promoting, pathogenic inflammation Cancer Research. 74: 3665-3665. DOI: 10.1158/1538-7445.Am2014-3665 | 0.607 | |||
2013 | Flick HE, Lalonde JM, Malachowski WP, Muller AJ. The Tumor-Selective Cytotoxic Agent β-Lapachone is a Potent Inhibitor of IDO1. International Journal of Tryptophan Research : Ijtr. 6: 35-45. PMID 24023520 DOI: 10.4137/IJTR.S12094 | 0.47 | |||
2012 | Smith C, Chang MY, Parker KH, Beury DW, DuHadaway JB, Flick HE, Boulden J, Sutanto-Ward E, Soler AP, Laury-Kleintop LD, Mandik-Nayak L, Metz R, Ostrand-Rosenberg S, Prendergast GC, Muller AJ. IDO is a nodal pathogenic driver of lung cancer and metastasis development. Cancer Discovery. 2: 722-35. PMID 22822050 DOI: 10.1158/2159-8290.Cd-12-0014 | 0.591 | |||
2012 | Smith C, Chang M, Flick H, DuHadaway J, Mandik-Nayak L, Laury-Kleintop L, Parker K, Beury D, Ostrand-Rosenberg S, Prendergast GC, Muller AJ. Abstract 295: IDO drives tumor-promoting, pathogenic inflammation in lung Cancer Research. 72: 295-295. DOI: 10.1158/1538-7445.Am2012-295 | 0.611 | |||
Show low-probability matches. |